The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Prevalence of Chronic Hepatitis B and Incidence of Acute Hepatitis B Infection in Human Immunodeficiency Virus–Infected Subjects
Abstract
We determined incidence and risk factors for acute and chronic hepatitis B virus (HBV) infection and HBV vaccination rates among human immunodeficiency virus (HIV)-infected subjects from the Adult/Adolescent Spectrum of HIV Disease Project, during 1998-2001. Among 16,248 HIV-infected patients receiving care, the incidence of acute HBV was 12.2 cases/1000 person-years (316 cases), was higher among black subjects (rate ratio [RR], 1.4; 95% confidence interval [CI], 1.0-2.0), subjects with alcoholism (RR, 1.7; 95% CI, 1.2-2.3), subjects who had recently injected drugs (RR, 1.6; 95% CI, 1.1-2.4), and subjects with a history of AIDS-defining conditions (RR, 1.5; 95% CI, 1.2-1.9) and was lower in those taking either antiretroviral therapy (ART) with lamivudine (RR, 0.5; 95% CI, 0.4-0.6), ART without lamivudine (RR, 0.5; 95% CI, 0.3-0.7), or >/=1 dose of HBV vaccine (14% of subjects) (RR, 0.6; 95% CI, 0.4-0.9). Prevalence of chronic HBV was 7.6% among unvaccinated subjects. HBV rates in this population were much higher than those in the general population, and vaccination levels were low. HBV remains an important cause of comorbidity in HIV-infected persons, but ART and vaccination are associated with decreased disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A One-Year Trial of Lamivudine for Chronic Hepatitis B
Lai, C.-L., Chien, R.-N., Leung, N. W. Y., Chang, T.-T., Guan, R., Tai, D.-I., Ng, K.-Y., Wu, P.-C., Dent, J. C., Barber, J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390201 · Cited by 1,754
LAMIVUDINE AS INITIAL TREATMENT FOR CHRONIC HEPATITIS B IN THE UNITED STATES
Ules, J., Ienstag, L. D., Chiff, E. U. R. S., Right, L. W., Errillo, R. O. P. P., Ann, L. H., Rowther, L. Y. C., Ondreay, D. C., Oessner, M. A. W., Ubin, M. A. R., et al. (1999) · Cited by 1,116
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
Thio, C. L., Seaberg, E. C., Skolasky, R., Phair, J., Visscher, B., Muñoz, A., & Thomas, D. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11913-1 · Cited by 1,099
A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
Dienstag, J. L., Perrillo, R. P., Schiff, E. R., Bartholomew, M., Vicary, C., & Rubin, M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332501 · Cited by 800
Risks of chronicity following acute hepatitis B virus infection: a review.
Hyams, K. C. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.992 · Cited by 521
Alter, M. J. (1990) · JAMA · doi:10.1001/jama.263.9.1218 · Cited by 458
The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.7.1019 · Cited by 429
Benhamou, Y., Bochet, M., Thibault, V., Di Martino, V., Caumes, E., Bricaire, F., Opolon, P., Katlama, C., & Poynard, T. (1999) · Hepatology · doi:10.1002/hep.510300525 · Cited by 424
McQuillan, G. M., Coleman, P. J., Kruszon-Moran, D., Moyer, L. A., Lambert, S. B., & Margolis, H. S. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.1.14 · Cited by 376
(1997) · PsycEXTRA Dataset · doi:10.1037/e547472006-001 · Cited by 305
Goldstein, S. T., Alter, M. J., Williams, I. T., Moyer, L. A., Judson, F. N., Mottram, K., Fleenor, M., Ryder, P. L., & Margolis, H. S. (2002) · The Journal of Infectious Diseases · doi:10.1086/339192 · Cited by 281
Spectrum of Disease in Persons With Human Immunodeficiency Virus Infection in the United States
Farizo, K. M. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480130114035 · Cited by 275
Hadler, S. C., Judson, F. N., O'Malley, P. M., Altman, N. L., Penley, K., Buchbinder, S., Schable, C. A., Coleman, P. J., Ostrow, D. N., & Francis, D. R. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.3.454 · Cited by 260
Hepatitis B and C in HIV-infected patients
Ockenga, J., Tillmann, H. L., Trautwein, C., Stoll, M., Manns, M. P., & Schmidt, R. E. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80274-7 · Cited by 240
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.6.965 · Cited by 142
THE EFFECT OF UNDERREPORTING ON THE APPARENT INCIDENCE AND EPIDEMIOLOGY OF ACUTE VHIAL HEPATITIS
Alter, M. J., Mares, A., Hadler, S. C., & Maynard, J. E. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114496 · Cited by 122
Impaired Response to Recombinant Hepatitis B Vaccine in HIV-Infected Persons
Bruguera, M., Cremades, M., Salinas, R., Costa, J. M., Grau, M., & Sans-Sabrafen, J. (1992) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199201000-00007 · Cited by 108
Hoff, J., Bani‐Sadr, F., Gassin, M., & Raffi, F. (2001) · Clinical Infectious Diseases · doi:10.1086/319368 · Cited by 88
Effect of influenza vaccination on disease progression among HIV-infected persons
Sullivan, P. S., Hanson, D. L., Dworkin, M. S., Jones, J. L., & Ward, J. W. (2000) · AIDS · doi:10.1097/00002030-200012010-00018 · Cited by 82
Self-citationSinicco, A., Raiteri, R., Sciandra, M., Bertone, C., Lingua, A., Salassa, B., & Gioannini, P. (1997) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549709035869 · Cited by 78
HIV and hepatitis B infection and risk behavior in young gay and bisexual men.
Seage, G. R., Kh, M., Wr, L., et al. (1997) · PubMed · Cited by 71
Tabet, S. R., Krone, M., Paradise, M. A., Corey, L., Stamm, W. E., & Celum, C. (1998) · AIDS · doi:10.1097/00002030-199815000-00016 · Cited by 68
Wilson, C. M., Ellenberg, J. H., Sawyer, M. K., Belzer, M. E., Crowley‐Nowick, P. A., Puga, A. M., Futterman, D. C., & Peralta, L. (2001) · Journal of Adolescent Health · doi:10.1016/s1054-139x(01)00278-6 · Cited by 59
Homann, C., Krogsgaard, K., Pedersen, C. B., Andersson, P., & Jø, N. (1991) · PubMed · Cited by 54
Koziol, D. E., Saah, A. J., Odaka, N., & Muñoz, Á. (1993) · Annals of Epidemiology · doi:10.1016/1047-2797(93)90073-d · Cited by 28
Failure of providers to vaccinate HIV-infected men against hepatitis B: a missed opportunity.
Rabeneck, L., Risser, J., Murray, N., McCabe, B. K., Lacke, C. E., & Lucco, L. J. (1993) · PubMed · Cited by 18
Cited by
Epidemiology of viral hepatitis and HIV co-infection
Alter, M. J. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.004 · Cited by 1,012
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
Weinbaum, C. M., Mast, E. E., & Ward, J. W. (2009) · Hepatology · doi:10.1002/hep.22882 · Cited by 815
Konopnicki, D., Mocroft, A., de Wit, S., Antunes, F., Ledergerber, B., Katlama, C., Zilmer, K., Vella, S., Kirk, O., & Lundgren, J. D. (2005) · AIDS · doi:10.1097/01.aids.0000163936.99401.fe · Cited by 569
Shouval, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00152-1 · Cited by 470
Metadata
- Authors
- Kellerman, S. E., Hanson, D. L., McNaghten, A. D., & Fleming, P. L.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-08-15
- Volume
- 188
- Issue
- 4
- Pages
- 571-577
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2102523161
- Cited by
- 282
- References
- 26
- FWCI
- 7.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.